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Background: Prostate cancer (PCa) bone metastasis can be markedly enhanced by increased receptor activator of
NF kappa-B ligand (RANKL) expression in PCa cells. Molecular mechanisms that account for the increased predilection
of PCa for bone include increased bone turnover, promotion of PCa cell growth and survival in the bone environment,
and recruitment of bystander dormant cells to participate in bone metastasis. The current study tests the hypothesis
that PCa cells acquire high adhesion to bone matrix proteins, which controls PCa bone colonization, under the RANKL/
RANK and AR axes.
Methods: We used a highly bone metastatic RANKL-overexpressing LNCaP PCa cell line, LNCaPRANKL, as a model to
pursue the molecular mechanisms underlying the increased adhesion of PCa cells to collagens. A three-dimensional
(3-D) suspension PCa organoid model was developed. The functions of integrin α2 in cell adhesion and survival were
evaluated by flow cytometry and western blot. AR expression and functionality were compared in 2-D monolayer
versus 3-D suspension cultures using AR promoter- and PSA promoter-luciferase activity. AR role in cell adhesion was
assessed using an adhesion assay.
Results: LNCaPRANKL cells were shown to adhere tightly to ColI matrix through increased α2 integrin expression. This
increased adhesion, concomitant with activation of the FAK and Akt pathways, was further enhanced by culturing
LNCaPRANKL cells in 3-D suspension. Under the influence of 3-D suspension culture, AR was restored in LNCaPRANKL cells
via downregulation of AP-4 transcription factor, and supported increased α2 integrin expression and adhesion to ColI.
Conclusion: 3-D suspension culture and in vivo PCa tumor growth restore AR through downregulation of AP-4,
enhancing integrin α2 expression and adhesion to ColI which is rich in bone matrices. The interactions of PCa
with ColI, mediated by integrin α2 and AR expression, could be a key molecular event accounting for PCa bone
metastasis.
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Prostate cancer (PCa) has the highest incidence and is
the second most common cause of cancer death among
men in western countries [1]. The main clinical compli-
cation causing morbidity [2,3] and mortality in PCa pa-
tients is bone metastasis, which presents in over 80% of
all men who die of PCa [4,5]. Despite the high occur-
rence of skeletal metastasis, the underlying molecular
mechanisms determining the predilection of PCa cells
for homing to bone are not well-understood. Previously,
we hypothesized that the osteomimetic properties of
PCa cells account for the predilection of PCa to me-
tastasize and grow in the bone microenvironment [6].
We found that β-2 microglobulin (β-2 M), a major his-
tocompatibility co-receptor, mediates the expression of
non-collagenous bone matrix proteins such as osteo-
calcin and bone sialoprotein in metastatic human pros-
tate cancer cell lines [7]. We found that upon the
induction of β-2 M, prostate cancer cells overexpress
RANKL, a protein intimately related physiologically to
bone turnover [8]. RANKL drives PCa cells to under-
go epithelial-to-mesenchymal transition (EMT) [9,10],
and when expressed by human cancer cell lines like
LNCaPRANKL, produces explosive skeletal and soft tissue
metastases upon intracardiac administration in mice [11].
Overexpression of RANKL plays a role in the breast
cancer osteolytic phenotype by binding to its RANK re-
ceptor on precursor osteoclasts [12]. Recent studies have
shown that RANKL positively correlates with higher
Gleason score in PCa [13] and predicts the survival of
PCa patients [14]. Denosumab, an anti-RANKL antibody
approved by the FDA for the management of osteopo-
rosis and breast and prostate cancer bone metastasis,
has been shown to improve or delay skeletal metastasis
in breast and prostate cancer by 35% [15] and 18% [16],
respectively. However, overall patient survival is not
affected, indicating the critical roles of other potential
factors affected by the RANK-mediated downstream sig-
naling network in PCa bone metastasis.
Another important factor in the development and pro-
gression of PCa is androgen receptor (AR) [17]. AR has
regulatory roles promoting PCa cell adhesion and survival
in bone. PCa cells are initially androgen-sensitive (AS) and
respond to androgen deprivation therapy (ADT) [17].
Overtime, while PCa cells remain AR positive, they pro-
gress to become androgen-insensitive (AI) and acquire in-
creased invasiveness and metastatic potential [18,19]. AI
tumors in hosts subjected to ADT become hypersensitive
to residual intracrine androgen due in part to AR gene
amplification, AR gene mutation, and/or higher AR regu-
lating transcription factors (TFs) [20-22]. Recently, AR
was found to induce cancer cell adhesion and survival
through integrin expression [23-25]. Since AR plays a sig-
nificant role in PCa metastasis, understanding how ARaffects PCa adhesion to collagen matrix in bone could
provide potential therapeutic approaches to block PCa
bone homing and increase patient survival.
Multivariable tumor and microenvironmental factors
are known to engage in tumor development and pro-
gression. Current 2-D monolayer culture lacks the rele-
vant cell–cell and cell–matrix interactions that occur
physiologically in the in vivo environment. This limi-
tation makes it extremely difficult or potentially impos-
sible to define the key cell signaling networks supporting
essential cellular functions in vitro [26,27]. Extracellular
matrix (ECM) mediates biological and physical cues ex-
ternal to the cell that result in altered cell proliferation,
migration, invasion, and adhesion. Cell-ECM communica-
tion is initiated through the interaction of α- and β-integrin
subunits to specific extracellular matrices [28,29] acti-
vating cell signaling pathways such as cell focal adhe-
sion kinase (FAK) [30,31]. 3-D in vitro models have an
invaluable ability to recapitulate some of the in vivo
cell-cell and cell-ECM interactions governing tumor
cell behavior [32,33].
In the present investigation, we used 3-D models to
test the possibility that increased PCa adhesion to bone-
derived ECM could promote PCa homing to bone. The
objectives of this study were: 1) To investigate if RANKL
overexpression promotes overexpression of integrins
that support the adhesion of PCa cells to bone matrix
proteins; 2) To determine if the levels of integrin expres-
sion are affected by growing PCa cells in 3-D suspension
culture; 3) To determine if AR can be restored in RANKL-
overexpressing LNCaP cells, and whether this restored AR
modulates integrin expression/function to increase the
growth, adhesion and survival of PCa cells in bone. To the
best of our knowledge, we illustrated for the first time that
overexpression of RANKL in human PCa cells induced
dramatic upregulation of integrin α2 expression which fa-
cilitated the adhesion of PCa cells, specifically to collagen
type I (ColI). We assessed and compared the adhesion of
PCa cells to ColI in 2-D vs. 3-D culture, and determined
the roles of FAK and Akt activation in PCa adhesion and
survival. We further assessed the overall effects of AP-4, a
newly identified regulator of AR, on cell adhesion to ColI
via increased α2 integrin expression.
Results
Comparison of LNCaPNeo and LNCaPRANKL cell adhesion,
integrated motility, and migration
Previous studies established that RANKL-overexpressing
LNCaP or ARCaP cells metastasized to bone and soft
tissues when inoculated intracardially [11,34]. We used
the RANKL-transfected LNCaP cell line, LNCaPRANKL,
to test the possibility that increased PCa cell homing to
mouse skeleton could be due to increased cell adhesion
and migration through a rise in integrin expression. We
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migration between LNCaPNeo and LNCaPRANKL cells
under 2-D versus 3-D growth conditions. Prior to the use
of 3-D conditions, we extensively compared the pros and
cons of culturing PCa cells under 2-D versus 3-D using
different substrata consisting of Matrigel, Hydrogel, poly-
meric PLGA mesh, and suspension culture in the presence
or absence of ColI. The morphologic features of PCa cells
under 2-D and 3-D growth conditions and their pros and
cons are presented in Additional file 1: Figure S1 and
Additional file 2: Table S1. Based on these comparative
studies, we concluded that 3-D suspension culture has the
definitive advantages of simplicity, ease of expanding into
large scale culture, low cost, and production of spheroidFigure 1 LNCaPRANKL cell adhesion and migration are enhanced in 3-D
to enhance the adhesion of PCa cells to ColI. For each condition, 5,000 single
96-well plates pre-coated with ColI, ColIV or FN. After 30 minutes of incubatio
LNCaPRANKL cells preferentially adhered to ColI, especially when the cells were
assay was conducted with cells pre-conditioned in 3-D suspension culture, w
with adhesion. The results are presented along with ratios to the control LNC
measurements from 2 independent experiments. (B) Time lapse fluorescence
motility of LNCaPRANKL cells was enhanced by 3 fold when the cells were pre-
normalized to LNCaPNeo cells and presented as the mean ± SD of 5 separate
migration potential of LNCaPRANKL cells. In the upper left panels, cells in 2-D m
healing assay. In the upper right panels, migration of cells pre-conditioned in
migration were quantified based on the results of 3 separate experiments.structures that can be easily handled for histopathologic
and immunohistochemical analyses of the cultured cells.
After these comparative studies, we compared the adhe-
sion and migration of LNCaPNeo and LNCaPRANKL cells
cultured in a 2-D monolayer rather than 3-D suspension.
Figure 1A shows that LNCaPRANKL cells attached to the
ColI and collagen IV (ColIV) extracellular matrices, better
than LNCaPNeo cells. Results indicate that the higher
adhesion of LNCaPRANKL cells to ColI-coated plates was
further enhanced when they were pre-grown in 3-D sus-
pension culture (Figure 1A; left panel). As expected, the
increased adhesion of LNCaPRANKL cells to ColI can be
antagonized by an anti-α2β1 antibody, where a 55% reduc-
tion of cell adhesion to ColI was observed within 30 minsuspension culture. (A) In the left panel, RANKL expression is shown
cells from 2-D monolayer or 3-D suspension culture were seeded on
n, the number of adherent cells was determined using alamarBlue assay.
pre-conditioned in 3-D suspension culture. In the right panel, a similar
here antagonizing antibody to α2β1 integrin was introduced to interfere
aPNeo cells for each condition. Each data point is the mean ± SD of 6
microscopy was used to determine cell motility. Compared to control,
conditioned in 3-D suspension culture. Integrated distance traveled was
experiments. (C) Pre-conditioning in 3-D suspension culture increased the
onolayer culture on ColI-coated plates were subjected to a wound
3-D suspension culture was assessed. In the lower panels, changes in cell
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anchored to ColI much more rapidly (within 30 minutes)
under 3-D suspension compared to growth in 2-D mono-
layer or compared to LNCaPNeo cells. The adhesion dif-
ference between the two cell lines and among different
ECMs was not significant after 3 hours (Additional file 3:
Figure S2). As illustrated, LNCaPRANKL cells also exhibited
higher adhesive properties to ColIV but not to FN or plas-
tic under suspension culture conditions. In sharp contrast,
LNCaPNeo cells had no preferential binding to collagens
(I and IV) under any of the culture conditions tested. The
higher ColIV binding preference of LNCaPRANKL cells
could explain their higher invasiveness through basement
membranes compared to their parental control LNCaPNeo
cells, as described previously [11]. In support of this obser-
vation, LNCaPRANKL cells exhibited greater integrated cell
motility in 3-D mOBM containing ColI [35] than on 2-D
ColI-coated plates, when compared to LNCaPNeo cells
(Figure 1B). We also found that while LNCaPRANKL and
its parental cell line have the same growth rate (data
not shown), LNCaPRANKL cells migrate farther than
LNCaPNeo cells under 3-D suspension conditions and in
the presence of ColI (Figure 1C).
Increased integrin α2 mediates activated phosphorylation
of FAK and Akt in LNCaPRANKL cells under 3-D suspension
growth
Among the known receptors for ColI, α2β1 subunits are
shown to be specific to ColI and play a critical role in PCa
[36,37]. Our preliminary comparative microarray analysis
of 2-D monolayer grown LNCaPNeo and LNCaPRANKL
cells revealed increased α2 integrin expression (Additional
file 4: Figure S3A). Using microarray data, we also found
that integrin α2 expression in LNCaP
RANKL cells was fur-
ther enhanced by subjecting LNCaPRANKL cells to 3-D
suspension culture (Additional file 4: Figure S3A). mRNA
and protein expression of integrin α2 was performed
in each condition and confirmed the microarray data
(Figure 2A, 2B). qRT-PCR analysis of cell embedded in
suspension containing 0.1 mg/ml ColI suggests that higher
expression of integrin α2 in cells could be further triggered
in the presence of ColI (Figure 2A). These results were
confirmed by FACS analysis comparing integrin α2
expression between LNCaPNeo and LNCaPRANKL cells
cultured under 2-D monolayer and 3-D suspension condi-
tions (Figure 2C). Quantitative analysis of FACS data re-
vealed that integrin α2expression of LNCaP
RANKL/
LNCaPNeo cells increased by 2.4 fold when cells were cul-
tured in 3-D suspension as opposed to 2-D monolayer
culture. FACS analysis did not show any significant
changes in α1 and β1 integrin expression. Increase in in-
tegrin α2 expression appeared to be controlled by the
RANKL/RANK axis, as the protein expression of RANKL
correlates with integrin α2 expression (Figure 2B). Thiswas further confirmed by using LNCaPRANKL cells with
RANK knocked down. Disrupting the RANKL/RANK
pathway resulted in reduced mRNA and protein expres-
sion of integrin α2 (Additional file 4: Figure S3B). Interes-
tingly, the protein expression of RANKL of LNCaPRANKL
cells grown in the 3-D suspension culture illustrates ex-
pression of the smaller band besides the total RANKL.
This band could represent a soluble RANKL. In a parallel
study using Elisa assay we have shown that soluble
RANKL only increases by 7% in LNCaPNeo cells when
compared 3-D suspension with 2-D monolayer. However,
this difference increases to 30% in LNCaPRANKL cells.
Higher soluble RANKL in 3-D suspension could be ex-
plained by potentially higher MMP7 expression in this
condition, which is known to be responsible for the clea-
vage of RANKL [38]. Corresponding with the increased
integrin α2, we also observed that LNCaP
RANKL cells
expressed higher levels of phosphorylated focal adhesion
kinase (FAK) and phosphorylated Akt, when compared to
2-D monolayer (Figure 2D). Interestingly, under 3-D
suspension conditions, LNCaPNeo parental cells showed
slightly lower p-FAK expression, while Akt phospho-
rylation was significantly higher. These data in aggregate
suggest that RANKL-expressing PCa cells grown in
3-D suspension have elevated cell adhesion and survival
capability and this is likely mediated by activated α2β1
integrin.
Other ECM receptors have been shown to play a role
in PCa invasion and migration including ColIV receptor,
α1β1 [39], laminin receptors, α3β1 [40] and α6β1 [25],
and fibronectin receptor, αvβ3 [41]. We compared the
microarray expression of α1, α3, α6, αv, β1, and β3 bet-
ween LNCaPNeo and LNCaPRANKL cells. Other than
increased integrin α2 expression, only integrin αvβ3
showed significantly increased expression in 3-D suspen-
sion versus 2-D monolayer culture (Additional file 4:
Figure S3A). However, we could not confirm the diffe-
rential expression of this integrin by FACS analysis (data
not shown). Additionally, we analyzed the cell surface
expression of integrin α2 in the androgen-refractory PCa
cancer cell line, ARCaP. Upon malignant progression,
ARCaPM cells are known to express high endogenous
RANKL [9] and fail to express functional AR [42].
ARCaPM cells were found to express lower levels of
integrin α2 than indolent ARCaPE cells (Additional file 4:
Figure S3C).
Restoration of AR expression in LNCaPRANKL cells in vivo
and in 3-D suspension culture enhances cell adhesion
to ColI
Since AR is diminished in metastatic LNCaPRANKL cells
compared to their parental LNCaPNeo cells, we tested the
possibility of restoring AR activity by growing LNCaPRANKL
cells in in vivo as tumor xenografts or 3-D suspension
Figure 2 RANKL overexpression induces integrin α2 expression, which mediates FAK and Akt phosphorylation. (A) LNCaP
RANKL cells
expressed increased α2 integrin as determined with qRT-PCR. The expression was the highest when the cells were grown in the 3-D suspension
that contained ColI. (B) Increased α2 integrin expression, appearing in a RANKL-dependent manner, was confirmed with western blotting. (C) In
the upper panels, cell surface expression of α1, α2 and β1 integrins was detected with FACS. Results indicate significantly higher α2 integrin expression
in RANKL-overexpressing cells grown in 3-D suspension. In the lower panel, the histogram represents the ratio of the surface integrin protein level of
LNCaPRANKL/LNCaPNeo cells quantified as median fluorescence intensity. Each value is the mean ± SD of two independent experiments. (D) Increased
α2 integrin is accompanied by higher p-FAK and p-Akt levels as determined by western blotting. For each group, the ratio of p-FAK/FAk and p-Akt/Akt
normalized to LNCaPNeo is shown. Blots were cropped to emphasize the relevant bands.
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LNCaPRANKL cells is undetectable when grown as a 2-D
monolayer. IHC staining of AR revealed positive staining
of LNCaPRANKL cells grown subcutaneously (Figure 3A).
Further, AR IHC staining was also observed in 3-D
suspension cultures of LNCaPRANKL cells and this was
confirmed by Western blot (Figure 3A, 3B). The restored
AR in LNCaPRANKL cells was shown to be biologicallyfunctional as revealed by increased PSA promoter luci-
ferase activity in LNCaPRANKL cells (Figure 3C). PSA
promoter luciferase activity was significantly elevated in
LNCaPRANKL cells grown in 3-D suspension culture as op-
posed to 2-D monolayer culture. Because AR was shown
to drive integrin α2 expression in PCa cells [23,43], we
asked if restoration of AR expression in LNCaPRANKL
cells, grown in 3-D suspension, enhanced cell adhesion to
Figure 3 Restored AR expression in LNCaPRANKL cells grown in 3-D suspension increases cell adhesion to ColI. (A) IHC analysis indicates
that the suppressed AR expression in LNCaPRANKL cells could be restored, when the cells were grown as a xenograft tumor or in 3-D suspension
culture. Arrows denote AR nuclear localization. (B) Restored AR in LNCaPRANKL cells grown in 3-D suspension was confirmed with western blotting.
While AR expression is high in LNCaPNeo cell grown in 2-D monolayer or 3-D suspension, LNCaPRANKL cells express AR protein only under 3-D
suspension conditions. (C) The restored AR is biologically functional since it could promote PSA promoter activity as detected by a PSA promoter-luciferase
reporter assay, which showed 4.3-fold increased activity in 3-D suspension culture compared to the LNCaPRANKL cells in 2-D monolayer. Each black bar
represents relative light unit (RLU) as a fold difference of 3-D suspension/2-D monolayer for each cell line. (D) The function of the restored AR protein
in regulating cell adhesion was indicated by treating LNCaPRANKL cells with the synthetic androgen R1881 (10 nM, 48 hours), which resulted in
significantly enhanced cell adhesion to ColI. On the other hand, the antagonistic effect of the anti-androgen casodex (20 nM) was seen mainly under
3-D suspension culture conditions. Each value is the mean ± SD of 2 independent experiments done in triplicate.
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3-D suspension were treated with 10nM R1881, an
androgen agonist, or 10 nM R1881 plus an AR antagonist,
Casodex (Bicalutamide, 20nM). Cell adhesion to ColI was
examined relative to plastic as a control. Under R1881
treatment, in either 2-D monolayer or 3-D suspension
culture, LNCaPRANKL cell adhesion to ColI compared to
plastic control was significantly higher by 4- and 9-fold,
respectively. Casodex was found to block the adhesion of
LNCaPRANKL cells to ColI by 1.3-fold in 3-D suspension
culture. As expected, AR antagonist did not affect the ColI
binding of LNCaPRANKL cells when grown in a 2-D mono-
layer because of the absence of detectable AR expression
under this culture condition (Figure 3D). These results
suggest that activated AR, in the presence of R1881 treat-
ment, induces integrin α2 expression and is responsiblefor the increased adhesion of LNCaPRANKL cells to a ColI
substratum.
Restoration of AR expression by downregulating
transcription factor AP-4
Our previous publication using site-directed mutagenesis
and transcription factor deletion/interference assays identi-
fied the suppressive action of AP-4 on AR expression [11].
We hypothesized that decreased AP-4 expression could
contribute to increased AR expression in LNCaPRANKL
cells grown in 3-D suspension. The qRT-PCR study of
AP-4 and AR expression, in LNCaPRANKL cells grown in
3-D suspension or in LNCaPRANKL cells after transient
transfection with AP-4 siRNA in 2-D monolayer, revealed
an inverse relationship between AP-4 and AR expression.
Unlike LNCaPNeo cells, LNCaPRANKL cells grown as 2-D
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lower AR. Upon AP-4 knockdown or in cells grown in
3-D suspension, AP-4 expression is reduced and this cor-
responds with increased AR expression (Figure 4A, B). AR
restoration was confirmed by both Western blot and in-
creased AR promoter luciferase activities (Figure 4C, D).
In support of the above observations, we also showed that
the restored AR was functional, capable of driving in-
creased PSA-promoter luciferase activity by 1.6 fold
(Figure 4E). In resemblance to AP-4 which induced
EMT in colorectal cancer [44], AP-4 siRNA transfected
LNCaPRANKL cells exhibited mesenchymal-to-epithelial
transition (MET), a reversal of EMT biomarker ex-
pression and decreased cell invasion (Additional file 5:
Figure S4A, B). Taken together, AP-4 could be the
molecular basis of AR restoration in LNCaPRANKL cells
cultured in 3-D suspension. Interestingly, however, en-
hanced AR expression by gene transfer into LNCaPRANKL
cells did not affect AP-4 expression (Additional file 5:
Figure S4C), suggesting that there is no established feed-
back loop between AR and AP-4.Figure 4 AR restoration was due to the suppression of AP-4 transcrip
provided a suppressing condition for the differential AP-4 expression observe
cells transfected with AP-4 siRNA could further reduce AP-4 expression as sho
relationship of expression as detected with qRT-PCR analysis. (C) Western blot
suppression by specific siRNA knockdown. (D) The effect of AP-4 appeared to
reporter luciferase assay. For each condition, RLU was shown as the fold differ
function was assessed by PSA-promoter reporter luciferase assay. In this experi
to androgen R1881 was then measured by PSA promoter reporter luciferase aDiscussion
The bone environment is enriched with cytokines,
growth factors, progenitor cells, and hematopoietic cells,
providing a suitable metastatic microenvironment to
promote PCa tumor cell adhesion, proliferation, migra-
tion, and survival. Despite this supportive microenvi-
ronment, cancer bone metastasis is a highly inefficient
process and occurs infrequently in cancer patients [45].
However, 80% of all PCa metastatic lesions exist in the
bone [4,5]. To understand the interactions between the
tumor and its microenvironment, we engineered an
indolent human PCa cell line, LNCaP, with RANKL. We
examined LNCaPRANKL and ARCaPM cells, which en-
dogenously expressed a high level of RANKL, for their
metastatic potential to bone and soft tissues. The results
consistently showed that RANKL drives these cells to
undergo EMT and assume many characteristics con-
sidered as metastatic cancer cell phenotypes, including
the expression of mesenchymal and stem cell bio-
markers, neuroendocrine and osteomimetic properties
[46], gaining the propensity for metastasis to bone andtion factor upon 3-D suspension culture. (A) 3-D suspension culture
d in RANKL-overexpressing cells in 2-D monolayer culture. LNCaPRANKL
wn with qRT-PCR analysis. (B) AR and AP-4 appeared to have an inverse
ting analysis was conducted to demonstrate AR restoration upon AP-4
modulate AR transcription, as determined with transient AR promoter
ence of AP-4 siRNA/SC siRNA transfection. (E) Effect of AP-4 on AR
ment, AP-4 was first knocked down in LNCaPRANKL cells. AR responsiveness
ssay.
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that RANKL protein administered by the intra-peritoneal
route can induce prostate cancer bone colonization in
mice, confirming the importance of the pathophysiological
role of RANKL as both autocrine and paracrine factor. In
this study, we specifically examined the effects of the
RANKL-RANK mediated signal network that drives PCa
cells to express selected integrin isotypes favoring their
adhesion to collagens, known to be rich in the bone
microenvironment. Our work reveals the importance ofFigure 5 Schematic summary of the role of RANKL-overexpression in
overexpression induced the expression of α2 integrin and AP-4 transcriptio
3-D suspension culture, α2β1 integrin was activated through RANKL expres
bone microenvironment. This activation would elicit FAK and Akt phospho
integrin activation was further enhanced through AP-4 downregulation, res
adhesion to ColI. We propose a possible positive feedback loop (dotted lin
under 3-D conditions to support cell anchoring and survival in the bone mthe 3-D culture environment that determines integrin ex-
pression via functional AR and ultimately affects the
pathophysiology of PCa metastases. The pathophysiologic
significance of our findings is depicted in Figure 5. 1)
RANKL/RANK signaling augments integrin α2 expression
in RANKL-transfected LNCaP cells but not in ARCaP
cells overexpressing RANKL intrinsically (Figure 2,
Additional file 4: Figure S3). This observation could pos-
sibly be due to the nearly undetectable levels of AR ex-
pression in the ARCaP cell line [42]. This suggests thatpromoting cancer cell adhesion. In LNCaPRANKL cells, RANKL
n factor. The later may account for the suppressed AR expression. In
sed by PCa cells or soluble RANKL expressed by stromal cells in the
rylation, resulting in enhanced cell motility, adhesion and survival. α2β1
ulting in AR accumulation that could play a role in LNCaPRANKL cell
e) between AR and integrin α2 regulation that is further enhanced
icroenvironment.
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ceptors [47,48], glycoprotein VI receptor [49], leukocyte-
associated Ig-like receptor [50] or mannose receptor
[51,52], could be downstream targets of the RANK-
mediated signal network that controls ARCaPM cell
progression and metastasis by interacting with collagen
matrices. 2) Consistent with the high bone metastatic be-
havior of LNCaPRANKL cells, we have shown for the first
time that integrin α2 expression is significantly enhanced
in a 3-D suspension model in a RANKL-dependent man-
ner (Figure 2). Exacerbated integrin α2 expression in-
creases the binding of these cells specifically to ColI, the
most abundant bone matrix protein (Figure 1). Their
profound cell binding to ColI and migration can clearly dis-
criminate indolent LNCaPNeo and metastatic LNCaPRANKL
cell lines when cultured in 3-D suspension. Concurrently,
we observed that anti-α2β1 antibody effectively antago-
nized LNCaPRANKL cell binding to ColI matrix (Figure 1).
Enhanced integrin α2 expression was shown to facilitate
the adhesion and survival of PCa cells through activated
FAK and Akt phosphorylation (Figure 2). High expression
of integrin α2 in metastatic PCa and its important role in
cell survival and adhesion in the bone microenvironment
is supported by recent experimental and clinical publica-
tions [53,54]. 3) Concomitant with enhanced integrin α2
expression, we also observed that LNCaPRANKL cells
grown in 3-D suspension exhibited elevated functional AR
expression, a result not seen in 2-D monolayer culture
(Figure 3). It worth mentioning, while functional assay of
AR on LNCaPRANKL cells showed 4.3 fold increases in
3-D suspension/ 2-D monolayer, the fold difference in AR
protein level seemed to be higher. However, we would not
expect a linear relationship between AR and its responsive
promoter-reporter activity due largely to the efficiency of
AR and its accessory transcriptional factors binding to the
promoters and also the efficiency of the translational
machinery of proteins in cells that ultimately determine
the promoter reporter activity. Moreover, inhibition of AR
nuclear translocation by Casodex treatment reduced
LNCaPRANKL cell adhesion to ColI (Figure 3), suggesting
that LNCaPRANKL cell adhesion through integrin α2 is po-
tentially AR-dependent. Our data are in agreement with
those of Nagakawa et al. [23] who showed that integrin α2
expression and ColI adhesion could be elevated by AR
expression in an AR-transfected PCa cell line, DU145. In
support of experimental studies, we used the publicly
available human prostate cancer genome data listed in
TCGA [55], to confirm a direct correlation between
mRNA expression of AR and integrin α2 (Spearman’s cor-
relation = 0.60, N = 302). Therefore, the adhesion of PCa
cells in the bone microenvironment could be enhanced by
modulating AR expression and function. While our study
and others suggest that AR could regulate integrin α2, we
were unable to find evidence that integrin α2 directlyincreases AR activity. Our studies of AR promoter did not
reveal any binding sites for integrin α2. However, further
studies are required to finally conclude whether integrin
α2 could directly or indirectly regulate AR expression. 4)
We further illustrated that AR restoration in LNCaPRANKL
cells under 3-D suspension condition is at the transcrip-
tional level via downregulation of a key TF repressor,
AP-4 (Figure 4). AP-4 overexpression concerts the up-
regulation of c-Myc/Max in RANKL-overexpressing PCa
cells [11] and drives EMT in colorectal cancer [44,56].
Similarly, downregulation of AP-4 with a concomitant
increased expression of AR and integrin α2 in PCa cells re-
sults in the reversal of EMT and reduced PC invasion
(Additional file 5: Figure S4). Because enhanced AR
activity was frequently observed in clinically advanced
PCa specimens [57,58], we hypothesize that enhanced AR
expression in LNCaPRANKL tumors could enhance the
adhesion and survival of LNCaPRANKL cells in mice. In
agreement with clinical observations and the role of
AP-4 downregulation, our preliminary data showed that
LNCaPRANKL cells overexpressing AR did have en-
hanced growth when inoculated as subcutaneous tumor
xenografts in mice (data not shown). Further in vivo
studies are warranted to determine if AR expression in
LNCaPRANKL cells could confer increased α2 integrin
expression and bone colonization through adhesion of
PCa cells to collagen matrix in the skeleton.
Our work reveals the importance of the 3-D culture en-
vironment that determines integrin expression via func-
tional AR and ultimately affects the pathophysiology of
PCa metastases. Our significant findings are as follows: 1)
The ability of PCa cells to adhere, survive and metastasize
to bone could be masked by culturing PCa cells as a 2-D
monolayer. We observed that RANKL-overexpressing
PCa cells have barely detectable AR when cultured on
plastic. When these cells were grown as 3-D suspensions
or in mice, AR was found to be restored and to activate
PSA promoter-luciferase activity. Additionally, we ob-
served higher adhesion of LNCaPRANKL cells to ColI in an
AR-dependent manner, most likely through increased ex-
pression of α2 integrin. These results are consistent with
the high levels of AR expression in clinical PCa bone me-
tastasis specimens. 2) The TF repressor, AP-4, was found
to be a negative regulator of AR at the transcriptional level
and is modulated in a cell context-dependent manner. We
speculate that AP-4 downregulation, epigenetically via
promoter methylation or genetically via AP-4 regulators
such as c-Myc, could play a decisive role in upregulating
the levels of AR. This could profoundly control the
responses of prostate tumors to androgen deprivation
therapy. 3) Upregulation of integrin α2 may be a common
path for human PCa to develop castration resistance and
bone metastasis. Balasubramaniam et al. recently studied
BAF57, a component of the switching-defective and
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complex conglomerate [59]. They found that BAF57 de-
regulation circumvented androgen-mediated signaling, up-
regulated α2 integrin expression, altered other SWI/SNF
complex components at the α2 integrin locus and con-
ferred a prometastatic migratory advantage on PCa cells
that could contribute to castration resistance and bone
metastasis in patients [60]. Hall et al. [36] demonstrated
experimentally that LNCaP cells selected for ColI binding
exhibit higher integrin α2 expression, become more adhe-
sive and migratory in in vitro and acquire the capacity to
grow within the bone compared to non-collagen binding
parental cells. These results are in agreement with work of
Colombel et al. [54] who showed that higher α2β1 protein
expression in primary PCa tissues correlates with bone
metastasis. Additionally, Sottnik et al. [53] demonstrated
elevation of α2β1 protein level in PCa skeleton metastases
when compared to primary site or soft tissue metastases.
These data along with our observations (Figure 2) sug-
gest that ColI can re-program cell fates by forcing the
expression of α2. Ultimately, through a RANKL- and
α2-mediated downstream signal network ColI can transdif-
ferentiate or reprogram non-metastatic PCa cells to gain
increased adhesion, growth and survival potential in the
bone microenvironment. More work is needed to build
clinically relevant alternative cell signaling network models
that could improve cancer diagnosis and prognosis and
offer targets for therapeutic intervention.
Conclusion
The survival of patients with skeletal metastasis is very
poor and more efficient prevention therapies are ur-
gently needed. Our understanding of the role of the
RANKL/RANK and AR axes in cancer cell adhesion is
evolving. Our study supports direct regulation of integ-
rin α2 and adhesion to ColI through RANKL/RANK sig-
naling. Previous experimental and clinical studies in
agreement with our data show the direct role of AR in
ColI adhesion, possibly through integrin α2 expression.
Our findings suggest that increased integrin activity
enhances bone adhesion in a RANKL/RANK and AR
dependent manner. Since there are studies supporting
the regulation of AR through cell-ECM interaction, it is
plausible that a positive feedback loop between AR and
integrin α2 is induced under 3-D and in vivo conditions
to support the growth and survival of PCa cells through
activated p-FAK and p-Akt. We anticipate expanding the
described 3-D suspension culture into co-culture models
where relevant cancer cells and normal cells of different
lineages can be constructed, studied and fully charac-
terized. We believe that 3-D suspension culture and the
co-culture of cancer cells with relevant cells in the
tumor microenvironment could provide important ad-
ditional insights into cancer plasticity and progression.Materials and methods
Cell culture
Cell lines and 2D culture conditions
LNCaP human prostate cancer progression models were
established by our laboratory as previously described [61].
The LNCaPNeo, LNCaPRANKL, and LNCaPRANKL cells with
RANK knockdown (LNCaPRANKL-RANK KD) cell lines were
established by Chu et al. [11]. LNCaP was maintained in
RPMI 1640 supplemented with 5% FBS. LNCaPNeo,
LNCaPRANKL, and LNCaPRANKL-RANK KD cells were also
maintained in RPMI 1640 (Invitrogen, Carlsbad, CA)
supplemented with 5% FBS with 200 ng/ml of Geneticin
selector. ARCaPE and ARCaPM cells established by
our laboratory [34,42] were maintained in T-medium
(Invitrogen, Carlsbad, CA) supplemented with 10% FBS.
MC3T3 cells (kindly provided by Dr. Neale Weitzmann,
Emory University, Atlanta, GA) were maintained in
DMEM supplemented by 10% FBS. All cells were incu-
bated in 5% CO2 atmosphere at 37°C.
3D culture conditions
Hydrogel
Hydrogel was prepared using the HyStem Hydrogel kit
(Glycosan BioSystem Inc. CA) according to the manufac-
turer’s instructions. In brief, Hystem and Extralink solu-
tions were prepared by dissolving the lyophilized solids in
DG water under aseptic conditions (1% w/v). Extralink
was added to the HyStem in 1:4 ratio. The final solution
was then incubated for 10 min before encapsulating the
cell pellet (10,000 cells/ ml). 200 μl of the final solution
was then plated in ultra-low attachment 24-well plates
(Sigma) within 20 min of encapsulation for full poly-
merization in the 37°C incubator for 30 min before adding
1 ml complete medium per well. Collagen type I (BD
Biosciences, 100 mg/ml rat tail) was added to the cell pel-
let at the 0.1 or 0.3 mg/ml final concentration (PH 7.0) be-
fore encapsulation, when specified. Medium was changed
every 3 days by removing 500 μl/well of the medium and
replacing it with 500 μl of fresh complete medium.
Suspension
LNCaPNeo and LNCaPRANKL cells, cultured on plastic,
were trypsinized at the log phase, washed and resus-
pended to a final concentration of 20,000 cells/ml. One
ml of the final solution was then plated in ultra-low at-
tachment 24-well plates (Sigma). Cells were maintained
in RPMI 1640 supplemented with 5% FBS, incubated in
5% CO2 atmosphere at 37°C and observed up to 12 days
to assess growth and morphology before harvest for
additional analysis. For ColI embedded cells, 0.1 or
0.3 mg/ml of ColI was added to the cell pellet before
adding the medium. Medium was changed every 3 days
by removing 500 μl/well of the medium and replacing it
with 500 μl of fresh complete medium.
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Poly (D,L-lactide-co-glycolide) (PLGA) fiber sheets (Mesh)
were kindly provided by Dr. JurgenGroll, University
Hospital, Würzburg, Germany [62]. Sheets 120 μm thick
were trimmed to 8 mm circles using a disposable biopsy
punch (Kia Medical, Inc) and placed in 48-well plates.
Wells were washed with 70% EtOH and twice with
1X PBS. Plates were left under UV light for 30 min before
use. LNCaPNeo and LNCaPRANKL cells were trypsinized at
the log phase, washed and resuspended to a final concen-
tration of 10,000 cells/ml. 500 μl of the final suspended
cells were plated in each well and grown for 7 days before
they were fixed or collected for further analysis. To study
the ColI interaction with cells, mesh fibers were coated
with 50 ng/ul of rat tail ColI (BD Biosciences).
Mouse osteoblast matrix (mOBM)
MC3T3-E14, mouse osteoblast precursor cells were
grown on 12-well plates (VWR) for 10 days to beyond
confluence. Cells were then treated with osteogenic
medium (100 nmol/L dexamethasone, 10 mmol/L beta-
glycerophosphate, and 0.05 mmol/L L-ascorbic acid-2-
phosphate) for an extra 3 weeks with medium changes
every 4 days, and then decellularized using 20nM of
sterilized ammonium hydroxide (NH4OH) for 30 min,
and washed extensively prior to seeding the cells [35,63].
In vivo experiments
All animal procedures were performed according to an
approved protocol from the Institutional Animal Care
and Use Committee of Cedars-Sinai Medical Center.
LNRANKL, LNRANKL-AR cells (2×106 cells/100 μl PBS) were
inoculated subcutaneously in 4-week-old male nude mice
(Taconic, Oxnard, CA). All mice were followed for total of
45 days. Tumor volume was measured every 3 days.
Microarray data analyses for AR and integrin α2 gene
signature
To identify potential correlations between AR and integ-
rin α2 in human samples, we used a dataset that prima-
rily included adenocarcinoma prostate cancer samples,
the Cancer Genome Atlas (TCGA) dataset (n = 336). Ex-
pression data for the TCGA dataset was downloaded
from the TCGA data portal (http://www.cbioportal.org/
public-portal/index.do).
Cell morphology
Samples were fixed with 3.7% formaldehyde permeabilized
with 0.2% Triton X-100 (Sigma) for 30 min and blocked
with 5% Bovine Serum Albumin (BSA) (Sigma) for 1 hour.
Samples were then washed with phosphate-buffered saline
(PBS), pH 7.4 and incubated with 4′-6-diamidino-2-phe-
nylindole (DAPI) (100 ng/ml, Invitrogen) and Alexa Fluor®
488 and 568 Phalloidin (4 μl/ml, Life Technologies) for1 hr in the dark for nucleus and f-actin cytoskeleton
staining, respectively. Phase-contrast images were then
captured using Nikon Eclipse Ti (NIKON instruments
Inc.). Organoids were placed on coverslip-bottom cham-
bers (Lab-Tek) and fluorescent confocal images were cap-
tured using Leica TCS-SP5 Xconfocol microscopy (Leica
Microsystems).
Microscopic live cell imaging and analyses
2×104 cells/ml were seeded on 12-well plates coated with
50 ng/μl or decellularized mOBM wells. A Nikon Eclipse
Ti inverted microscope equipped with an automotive
x-y-z stage was used for multiposition and perfect focus
system time-lapse microscopy. An environmental cham-
ber was used to maintain humidity, 5% CO2, and 37°C
temperature. FITC and TRITC filters with a shutter con-
trol (Lamda SC, Smart Sutter Controller) and a CCD
Head camera (Andor Technology) were used for fluo-
rescent imaging. All imaging was performed using a 10×
phase contrast (Nikon Plan Fluor Ph1) objective. All the
images were also converted to TIF files for analysis of
shape and integrated distanced traveled using CellProfiler
2.1.0 (Broad Institute, Boston, MA).
RNA isolation and quantitative real-time PCR (qRT-PCR)
Total RNA from cells was isolated using an RNeasy Mini
Kit (Qiagen, Valencia, CA) according to the manufac-
turer’s instructions. RNA concentration was quantified
using the Nanodrop-2000 (ThermoScientific). Samples
with a 260/280 ratio higher than 1.8 were used for sub-
sequent procedures. Complementary DNA (cDNA) was
generated from 1 μg of total RNA using M-MLV reverse
transcriptase (Promega, Madison, WI), as instructed.
20 ng of cDNA was subjected to PCR analyses using an
AB 7500 Fast detection system (Applied Biosystems,
Foster City, CA) at 95°C for 10 min and 40 cycles of 95°C
for 30 sec, 60°C for 30 sec, and 72°C for 30 sec, followed
by a dissociation curve. The sequences of all primers used
are listed in Table 1.
Western blot analysis
LNCaPNeo and LNCaPRANKL cells were cultured in 6-well
plates under 2-D monolayer conditions to 70% confluence
or in 3-D suspension conditions for 7 days. The cells were
then pelletized and washed with PBS before being lysed in
RIPA buffer (1% Triton X-100, 150 mM NaCl, 10 mM
Tris/HCl, 1 mM EDTA and 25 mM NaF) containing 1×
protease inhibitor cocktail (Roche Diagnostics, Indianapo-
lis, IN). Samples were then centrifuged and the superna-
tants collected and quantified using the Bradford Protein
Assay (Thermo Fisher Scientific, Waltham, MA). 20 μg of
cell lysate were resolved on 4-15% Bis-Tris gradient SDS-
PAGE (BioRad, Hercules, CA), followed by transblotting
onto nitrocellulose membrane (BioRad, Hercules, CA).
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for one hour at room temperature (RT) and incubated with
diluted primary antibodies in blocking buffer at 4°C over-
night. The primary antibodies used were AR (1:500), integ-
rin α2(1:500), β-actin (1:2000), AP-4 (1:500, Santa Cruz),
FAK (1:1000, Abcam), p-FAK (1:1000), Akt (1:1000), p-Akt
(1:2000), c-Met (1:1000), and p-c-Met (1:1000, Cell
Signaling). The membranes were washed with TBST three
times before incubating with peroxidase-conjugated anti-
mouse or anti-rabbit secondary antibodies (1:10000, Santa
Cruz) at RT for one hour. After three washes, the
membranes were visualized using Kodak Image Station
4000MMProinstrument (AFAB Lab resources, Frederick,
MD) and Carestream MI SE Network software. Images
were cropped to improve the clarity of the figures. Each
image is representative of two separate studies.
Fluorescence Activated Cell Sorter (FACS)
LNCaPNeo and LNCaPRANKL cells were detached from
2-D monolayer using accutase (Millipore) to preserve
membrane receptors. Organoids from 3-D suspension
culture were made into single cells using a final concen-
tration of 1 mg/10 ml collagenase in accutase and
20 min incubation at 37°C. Cells were then washed and
resuspended into single cell suspension in 1 × PBS con-
taining 1% FBS (FACS buffer). After two washes with
cold FACS buffer, cells were incubated for 30 min on ice
with FITC-tagged anti-human CD49a, CD49b, CD51/61
and PE anti-human CD29 (BioLegend) or isotype con-
trol FITC mouse IgG1, k (eBioscience). Antibodies were
washed twice with FACS buffer. Cell fluorescence signals
were determined immediately after staining using a BD
Accuri C6 flow cytometer (BD Biosciences) equipped
with an argon laser emission of 488 nm. FITC and PE
were identified using a 530 ± 15 nm and 585 ± 20 nm
band pass filter, respectively. The analysis was performed
using FlowJo software (TreeStar Inc.). A primary gate
was set excluding dead cells or debris based on physicalparameters (forward and side light scatter, FSC and SSC,
respectively).
Adhesion assay
The adhesion assay was a modification of a previously pub-
lished protocol [64]. For each condition, 1×105 cells/ml
were placed in 15-ml conical tubes and 10 μg/ml α2β1
blocking antibody (VLA-2 Millipro) or IgG1 isotype con-
trol (bioLegend) was added and incubated for 20 minutes
at room temperature. Binding assays were performed by
seeding 5000 cells in 100 μl of complete medium on plas-
tic or fibronectin-, collagen-IV-, or collagen I-precoated
96-well plates (BD Biosciences). At 30 min, 1-, 3-, 6-, 12-
and 24-hr time points, wells were washed twice with PBS,
100 μl of complete medium was replaced, and 10 μlof ala-
marBlue (Invitrogen) was added, according to the manu-
facturer’s instructions. After 12 hrs incubation at 37°C in
the dark, the plates were read using the Spectra max M2
microplate reader (Molecular Devices, Sunnyvale, CA) at
590 nm with Softmax Pro software. All the readings were
normalized to the reading of the well with no cells as a
background measurement. The initial activity of the cells
was measured by adding 10 μl of alamarBlue directly to
the well without washing the cells.
For cells treated with R1881 and/or Casodex, serum-
starved medium with 5% dextran-coated charcoal was
used instead of complete medium. Plates were washed at
30 min and 1 hr time points and read after 12 hrs of ala-
maBlue assay. Each condition was performed in tripli-




IHC staining was applied to cells grown as in vitro 2-D
monolayers. Cells were grown directly on 8-chamber
slides to 80% confluence. In some cases, cells were
grown as in vitro 3-D organoids. Organoids harvested
from the 3-D suspension culture were carefully collected
into 1.5 ml eppendorf tubes and spun down to a pellet.
1% LMP agarose solution was prepared and added to
the pellet. After solidification, using a micro spatula,
agarose-cell pellets were wrapped in tissue paper, placed
in a plastic tissue cassette, and tissue processing was
performed overnight using an automated tissue proces-
sor. For in vivo tissues, subcutaneous tumors were
collected and fixed in 4% formaldehyde immediately for
24 hrs. The next day, tumors were processed for paraffin
embedment as described above.
Histology analysis
IHC was followed according a previously published proto-
col [10]. All reagents from the DAKO system (Carpinteria,
CA) were used for immunoperoxidase staining of the
Ziaee and Chung Molecular Cancer 2014, 13:208 Page 13 of 16
http://www.molecular-cancer.com/content/13/1/208sectioned slides. Paraffin-embedded slides were rehydrated
and antigenic epitopes were retrieved in citrate buffer
using a pressure cooker. After antigen retrieval, slides
were blocked with dual endogenous enzyme block (DEEB)
at RT for 10 min and incubated with primary antibodies
against AR (Santa Cruz) at 4°C overnight. The slides were
placed at RT for 1 h, rinsed in Tris-buffered saline with
0.05% Tween (TBST) and incubated with Envision +
Labeled Polymer-HRP at RT for 30 min. The slides were
incubated with peroxidase substrate buffer with a chro-
mogen, diaminobenzidine (DAB), to detect the staining
signal, followed by hematoxylin counterstaining of nuclei.
After dehydration and cover-slipping, the slides were
examined by light microscopy. For monolayer samples,
slides were blocked without the peroxidase step.
Transient transfection and luciferase reporter assays
AR [65] promoter-luciferase plasmid DNA and control
CMV-TK plasmid DNA (for transfection efficiency con-
trol) were transiently transfected into prostate cancer cells
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) for
48 hrs. The cells were then harvested and protein lysate
extracted using 1× passive lysis buffer (Promega, Madison,
WI). The lysate was centrifuged at 13,200 rpm at 4°C
for 10 min, and the supernatant was collected for luci-
ferase assay. Promoter and TK activity was measured
using Dual-Glo luciferase assay, as instructed (Promega,
Madison, WI). In short, 20 μl of protein lysate was mixed
with 100 μl of substrate (luciferin) and luciferase activity
was measured using a BD Monolight 3010 luminometer
(BD Pharmingen, San Diego, CA). TK activity was mea-
sured by immediately adding 100 μl of Stop&Glo buffer
with 50× Stop&Glo substrate to the mix and re-measuring
the samples. The relative luciferase activity of each sample
was calculated by normalizing to the TK activity. To assess
PSA [66] promoter-luciferase activity, we followed the
same procedure as above. In addition, cells were serum-
starved for 24 hrs before treatment with either 10 nM
ethanol or R1881 for another 48 hrs before harvest. Each
condition was done in quartet and two independent ex-
periments were carried out per assay.
Migration and invasion assays
Cell migration and invasion analysis were performed in a
24-well plates using Transwell™ chambers (BD Biosciences).
As described previously, transwells were coated with colla-
gen type I or growth factor reduced Matrigel (BD Biosci-
ences) for migration or invasion assay, respectively.
LNCaPNeo, LNCaPRANKL-control and LNCaPRANKL-AP-4 KD
were serum-starved in RPMI 1640 overnight. The next
day, transwells were placed on 24-well plates with 400 μl
of complete medium. 100 μl of serum-free RPMI 1640
containing 5x104 cells were seeded inside the chambers
for 24 hr (migration) or 48 hr (invasion) at 37°C. At eachtime point, cells remaining on the transwell were fixed
with 10% formaldehyde and stained with 0.5% crystal vio-
let. Cells inside the chamber were cleared and remaining
cells where quantified [67].In vitro healing assay and 3D migration assay
24-well plates were coated with 50 ng/μl rat tail ColI
and stored at 4°C overnight. Wells were washed twice
with PBS before use. For the 2-D wound healing assay,
cells were seeded in 24-well plates and cultured to
90% confluence. A straight scratch was made using a
1,000 μl pipette tip to simulate a wound. Wells were
washed with 1X PBS to remove unattached cells. Wells
were imaged at time zero and after 24 hrs using the 4×
objective. Images were analyzed using ImageJ and the
distanced traveled was measured. Three images were
taken of each triplicate well for two independent experi-
ments. For the 3-D migration assay, organoids were
taken from 7-day suspension culture and placed on
24-well ColI-coated plates. Images were captured right
after seeding and at 24, 48, and 72 hrs. The area covered
by the cells was measured using ImageJ and compared
between the two cell lines at each time point. The study
was done in triplicate for two independent experiments.Cell transfection and transduction protocol
LNCaPRANKL cells were grown in 6-well plates to 60%
confluence, then transfected with 100 pmol final con-
centration of AP-4 siRNA or control siRNA (Santa Cruz
Biotechnology, Inc.) for 48 hrs, using Lipofectamine
2000 (Invitrogen, Carlsbad, CA). Samples were collected
for qRT-PCR and western blot analysis or further trans-
fected with AR or PSA promoter for the luciferase pro-
moter assay as described above.
For cell transduction, LNCaPRANKL cells were grown
in 48-well plates to 50% confluence 24 hrs before trans-
duction. Next day, the complete medium was replaced
with complete medium containing Polybrene at a 5 μg/ml
final concentration. Cells were infected with AP-4 or con-
trol sh-RNA lentiviral particles (Santa Cruz) for 24 hrs.
Cells were cultured for an extra 24 hrs before being split
to 1:3 ratio. Cell selection was started after an additional
24 hrs with 2 μg/ml of Puromycin.Microarray analysis
RNA was isolated as above, hybridized to human
U133plus2.0 array, and Affymetrix Gene Chip Ex-
pression Analysis was performed (UCLA Clinical
Microarray Core). The microarray data was first pre-
processed with quantile normalization. Genes were se-
lected based on Students T- tests with P <0.05 and fold
changes >2.
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Differences between groups were analyzed using Student’s
t-test. A p-value < 0.05 was considered statistically signifi-
cant (denoted by an asterisk). At least three independent
in vitro experiments were conducted in triplicate for all
assays and analyses, unless otherwise specified.
Additional files
Additional file 1: Figure S1. Morphological features of prostate cancer
cells in 2-D monolayer and 3-D suspension cultures. The growth of
RANKL-overexpressing LNCaP cells was evaluated in 2-D monolayer or in
3-D embedded in hydrogel, on polymeric meshes, and in suspension
cultures, in combination with the addition of ColI. The control LNCaPNeo
cells formed massive spheroids with hollow lumens (not shown) and
exhibited clear invadopodia in the presence of ColI. In comparison,
LNCaPRANKL cells formed only loosely-aggregated organoids in 3-D
suspension culture, but were mostly in dispersed growth in other cultures.
DAPI staining is shown in blue, and F-actin staining is green in 2-D
monolayer but yellow in Mesh or 3-D suspension culture.
Additional file 2: Table S1. Assessments of 3-D culture conditions. 2-D
monolayer culture on plastic was compared with models of 3-D cultures
in matrigel, hydrogel, Mesh, and in suspension. 3-D suspension culture
was found to be superior in terms of biological relevance, sample
production for further molecular analysis, time and cost efficiency, and
ease of operation.
Additional file 3: Figure S2. Transient differences in the adhesion of
LNCaPNeo and LNCaPRANKL cells to ECM proteins. Cells grown on a 2-D
monolayer or in 3-D suspension were harvested in single-cell preparation.
For each group, 5,000 cells were seeded on 96-well plates coated with
ColI, ColIV, or FN. Adhered cells at different times of incubation were
determined by alamarBlue assay. Each value is the mean ± SD of 2
independent experiments done in triplicate.
Additional file 4: Figure 3. Integrin expression was regulated by RANKL
and by the 3-D suspension culture condition. (A) The expression of integrin
isoforms was profiled by microarray analysis. Values represented fold
changes in LNCaPRANKL cells compared to the LNCaPNeo control. As signified
in red, α2, αv and β3 integrins had more than 2 fold increases when grown
in 3-D suspension. (B) The expression of α2 integrin appeared to be
dependent on the RANKL/RANK pathway, as reduced expression was seen
by qRT-PCR and western blot when the pathway was interfered with RANK
knockdown (RANK-KD). (C) Top panels, human prostate cancer ARCaPE and
ARCaPM cells grown on a monolayer were stained for α1 and α2 integrins
for FACS analysis. Bottom Panel, quantification of the FACS detection
suggested that α2 integrin expression was lower in the more aggressive cell
line ARCaPM compared with ARCaPE cells.
Additional file 5: Figure S4. Suppressing AP-4 led to reversal of EMT
and a decrease in cell invasion. (A) LNCaPRANKL cells treated with AP-4
siRNA were studied for EMT markers at the mRNA and protein level.
Upon AP-4 KD, vimentin expression was reduced while E-cadherin
was increased. (B) LNCaPRANKL cells treated with AP-4 shRNA showed
significantly decreased invasive potential, while no changes in migration
were observed. (C) AR expression vector was used to express AR in
LNCaPRANKL cells (LNCaPRANKL-AR). No changes in AP-4 expression were
found by qRT-PCR analysis, compared to cells transfected with an empty
vector (LNCaPRANKL-EV).
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